Did you know?

ChinaBio® Group is a consulting and advisory firm helping life science companies and investors achieve success in China. ChinaBio works with U.S., European and APAC companies and investors seeking partnerships, acquisitions, novel technologies and funding in China.  

Learn more >>

Free Newsletter

Have the latest stories on China's life science industry delivered to your inbox daily or weekly - free!

See preview >>

  Email address:
   

Sirnaomics Starts Trial of Lead siRNA Therapy for Fat Reduction

publication date: Nov 9, 2022

Sirnaomics, a Suzhou-Maryland RNAi company, has dosed the first patient in a Phase I clinical study of its lead siRNA (small interfering RNA) candidate as a fat reduction agent in adults undergoing abdominoplasty. STP705 is already being tested as a therapy for cholangiocarcinoma, non-melanoma skin cancer and hypertrophic scar. Sirnaomics said the dose setting trial will examine STP705 for its fat reduction and subcutaneous tissue remodeling effects, pointing out that existing therapies require multiple sessions to produce only mild effects. More details....

Stock Symbol: (HK: 2257)

Share this with colleagues:  


This article is available for purchase - please click here for details.

Sorry this page is available to subscribers only.
If you're not a subscriber why not subscribe today?

If you are already a subscriber, please login.

If you believe you should have received this message in error, please contact us.


 

To gain access to the members only content click here to subscribe.

You will be given immediate access to premium content on the site.

Upcoming Events

ChinaBio® Partnering Forum
September 10–11, 2024 | Shanghai, China
Register here

BIO-Europe®
November 4–6, 2024 | Stockholm, Sweden
Save €900 before September 13!
Register here

Biotech Showcase™
January 13–15, 2025 | San Francisco, CA
Save $600 before September 27!
Other Relevant Events

Antibody Engineering & Therapeutics Asia
October 21–23, 2024 | Kyoto, Japan
Save 30% with code CHINABIO30!
Register here